The Departments of Labor, Health and Human Services, and the Treasury have issued ACA FAQs Part 69 offering guidance on the No Surprises Act (NSA) and Gag Clause Prohibition and related attestation requirements under the Consolidated Appropriations Act, 2021 (CAA). The guidance covers downstream agreements, restrictions on providing de-identified claims data to a business associate and noncompliance reporting. In addition, the departments are extending enforcement relief for qualifying payment amount (QPA) calculations under the NSA.
The CAA prohibits group health plans and health insurance issuers from entering into an agreement — with a healthcare provider, network or association of providers, third-party administrator (TPA) or other service provider offering access to a provider network — containing any gag clause that would prevent the plan from doing any of the following:
In addition, plans and issuers must annually affirm that they adhere to these requirements by submitting a Gag Clause Prohibition Compliance Attestation (GCPCA). The first GCPCA was due by December 31, 2023, covering the period beginning December 27, 2020, or the effective date of the group health plan or health insurance coverage (if later), through the date of attestation. Subsequent attestations, covering the period after the preceding GCPCA, are due by December 31 of each year.
Discussed below are key areas covered in the recent guidance for group health plans and their sponsors.
If a plan has a contract with a TPA or other service provider that offers access to a provider network, and the TPA or other service provider also has separate agreements with other entities to provide or administer the plan’s network (referred to as downstream agreements), then the downstream agreement must meet the gag clause prohibition requirements.
The Gag Clause Prohibition prohibits a plan or issuer from entering into any agreement with a healthcare provider, network or association of providers, TPA or other service provider offering access to a provider network that prevents or limits the plan or issuer from sharing de-identified claims data with a business associate.
The FAQs provide examples of restrictions on access to de-identified claims and encounter information or data that are prohibited by the Gag Clause Prohibition. (Note: This is not an exhaustive list. Additional examples of prohibited gag clauses may be provided in future guidance.)
When filing an annual GCPCA, plans and issuers that become aware of an existing agreement that violates the Gag Clause Prohibition must identify the non-compliant provision within the “Additional Information” text box in the GCPCA webform system.
The NSA helps protect against surprise medical bills for group health plan participants using certain out-of-network services. Previous regulatory guidance established a Federal Independent Dispute Resolution (IDR) process for resolving disputes between plans or issuers and providers, facilities or providers of air ambulance services about out-of-network rates. The guidance included provisions on calculating the QPA to determine the cost-sharing amount an individual must pay. The QPA is generally the median of the contracted rates of the plan or issuer for the item or service in the geographic region, adjusted for inflation.
On August 24, 2023, the provisions for calculating the QPA were vacated by a U.S. District Court. The Fifth Circuit Court later reversed the District Court’s decision of certain challenged provisions related to the QPA methodology, including the inclusion of contracted rates for items and services “regardless of the number of claims paid at that contracted rate”; the exclusion of single case agreements; and the exclusion of bonus, incentive and risk-sharing payments.
Recognizing the challenges plans and issuers now face when recalculating QPAs in light of these court decisions, the departments have extended their enforcement discretion to items and services furnished before August 1, 2025, for any plan or issuer, or party to a payment dispute in the Federal IDR process, that uses a QPA calculated in accordance with the prior regulatory guidance.
Employer plan sponsors should: